FY2025 Earnings Forecast for PRE Issued By Cantor Fitzgerald

Prenetics Global Limited (NASDAQ:PRE) – Research analysts at Cantor Fitzgerald issued their FY2025 EPS estimates for shares of Prenetics Global in a report issued on Tuesday, January 21st. Cantor Fitzgerald analyst R. Osborn expects that the company will post earnings per share of ($2.08) for the year. Cantor Fitzgerald currently has a “Overweight” rating and a $9.00 target price on the stock. The consensus estimate for Prenetics Global’s current full-year earnings is ($3.30) per share.

Prenetics Global (NASDAQ:PRE) last announced its earnings results on Wednesday, November 27th. The company reported ($0.84) earnings per share (EPS) for the quarter. Prenetics Global had a negative return on equity of 16.45% and a negative net margin of 191.73%.

Prenetics Global Trading Down 4.7 %

NASDAQ:PRE opened at $5.72 on Wednesday. The firm has a market cap of $51.67 million, a price-to-earnings ratio of -1.43 and a beta of -0.30. Prenetics Global has a 12-month low of $2.85 and a 12-month high of $7.84. The company’s 50-day moving average is $5.30 and its two-hundred day moving average is $5.09.

About Prenetics Global

Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies.